Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

357
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
357
Menopause01:28

Menopause

156
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
156
Oogenesis02:07

Oogenesis

63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re-irradiation for recurrent esophageal cancer: clinical benefit, survival outcomes, and toxicity profile.

Clinical and translational radiation oncology·2025
Same author

Cardiovascular outcomes and aortic growth in pregnant women with Turner syndrome: data from the ESC EORP Registry Of Pregnancy And Cardiac disease (ROPAC) III.

European journal of preventive cardiology·2025
Same author

Use of p53 immunohistochemistry can improve diagnostic agreement for differentiated vulvar intraepithelial neoplasia (dVIN): an international reproducibility study.

Histopathology·2025
Same author

NTCP models based on CT-guided online adaptive SBRT for abdominal lymph node oligometastases.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

Pregnancy outcomes in women with heritable thoracic aortic disease: data from the EORP ESC registry of pregnancy and cardiac disease (ROPAC) III.

European heart journal. Quality of care & clinical outcomes·2025
Same author

Ureter Tolerance in Patients Treated with Stereotactic Body Radiation Therapy on Abdominopelvic Lymph Nodes: Analysis on Dose-related Late Effects.

International journal of radiation oncology, biology, physics·2025

Related Experiment Video

Updated: Jun 27, 2025

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
05:16

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

3.4K

Recurrent postmenopausal bleeding: Pathological findings and predictive factors. A multicenter, prospective,

Laura D P R van Maldegem1, Johanna A van der Zande1, Lucy A van Werkhoven1

  • 1Department of Gynecologic Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Acta Obstetricia Et Gynecologica Scandinavica
|May 2, 2024
PubMed
Summary

Recurrent postmenopausal bleeding (PMB) is common and linked to benign polyps, not higher cancer risk. Hormone replacement therapy and initial polyps predict recurrence.

Keywords:
endometrial cancerendometrial neoplasmsendometrial polyppostmenopausal bleedingrecurrencerecurrent postmenopausal bleeding

More Related Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.0K
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.1K

Related Experiment Videos

Last Updated: Jun 27, 2025

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
05:16

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

3.4K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.0K
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.1K

Area of Science:

  • Gynecology
  • Oncology

Background:

  • Recurrent postmenopausal bleeding (PMB) affects 6%-25% of women with prior episodes.
  • The link between recurrent PMB and endometrial cancer (EC) risk remains debated.
  • Predictive factors for recurrent PMB are not well understood.

Purpose of the Study:

  • To determine the incidence of recurrent PMB.
  • To compare pathological findings in single vs. recurrent PMB episodes.
  • To identify factors predicting recurrent PMB.

Main Methods:

  • A 5-year multicenter prospective cohort study in the Netherlands.
  • Included women aged 40+ with PMB undergoing endometrial sampling.
  • Retrospectively determined recurrent PMB and analyzed outcomes.

Main Results:

  • 26.4% of women experienced recurrent PMB over 61 months.
  • Recurrent PMB was associated with more benign polyps (34.7% vs 25.1%) and less malignancy (5.3% vs 17.8%).
  • Hormone replacement therapy (HRT) and initial benign polyps predicted recurrent PMB.

Conclusions:

  • Recurrent PMB is frequent in women with prior episodes.
  • Recurrent PMB with benign initial findings is linked to fewer malignancies and more benign polyps.
  • Benign polyps at first PMB predict recurrence but not increased malignancy risk.